Home Health Care Progenics reports $10.7m loss as revenue falls by $73m

Progenics reports $10.7m loss as revenue falls by $73m

SHARE

Progenics said the loss was due to decreased revenue from its collaboration with Salix Pharmaceuticals, which has the development and marketing rights to Progenics’ first commercial product, Relistor.

This content is for Westfair Online members only. Please to view this content. Become a member by Registering Here.
Print Friendly, PDF & Email